Michael W. Jann
- 4Articles
- 14KReads
- 1998–2001Active
- 12Collaborators
- 142Citations
About
Michael W. Jann has published research focused on the pharmacokinetics and clinical management of clozapine in patients with schizophrenia and schizoaffective disorders. His work includes studies on the effects of grapefruit juice ingestion, fluvoxamine co-administration, and factors such as gender and age on clozapine plasma levels. He has also investigated changes in clozapine concentrations following phenobarbital discontinuation. Jann's articles appeared between 1998 and 2001 in Psychiatrist.com publications.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
